Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...
Pharmaceutical Technology on MSN
Takeda and Protagonist seek FDA approval for rusfertide to treat PV
Takeda and Protagonist Therapeutics have jointly submitted a new drug application (NDA) seeking approval from the US Food and ...
A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...
Please provide your email address to receive an email when new articles are posted on . Single dose of DISC-0974 shows positive safety and tolerability profiles among healthy patients. This dose also ...
Long-term protective effects of the angiotensin-receptor blocker telmisartan on epirubucin-induced inflammation, oxidative stress, and myocardial dysfunction. Hepcidin 1st tertile 6/47 (13%) 4/41 (10% ...
Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2-3% of the global population. The condition is characterized by red, scaly ...
June 1, 2012 (Paris, France) — Vitamin D supplementation is safe and economic for patients with chronic kidney disease (CKD); it can also decrease the need for erythropoietin-stimulating agents and ...
Therapeutic iron supplements may be less effective when given in brief intervals: A peptide molecule blocks iron absorption in the intestine even 24 hours after the iron administation, say researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback